• 1
    Pieringer H, Pichler M (2011) Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM 104, 1326.
  • 2
    Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59, 16907.
  • 3
    Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108, 295763.
  • 4
    Gonzalez A, Maradit Kremers H, Crowson CS et al. (2008) Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis 67, 649.
  • 5
    Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 113, 148994.
  • 6
    Diaz A, Bourassa MG, Guertin MC, Tardif JC (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26, 96774.
  • 7
    Verrier RL, Tan A (2009) Heart rate, autonomic markers, and cardiac mortality. Heart Rhythm 6, S6875.
  • 8
    Fox K, Borer JS, Camm AJ et al. (2007) Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50, 82330.
  • 9
    Perski A, Hamsten A, Lindvall K, Theorell T (1988) Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients. Am Heart J 116, 136973.
  • 10
    Sa Cunha R, Pannier B, Benetos A et al. (1997) Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens 15, 142330.
  • 11
    Heidland UE, Strauer BE (2001) Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 104, 147782.
  • 12
    Chemla D, Nitenberg A, Teboul JL et al. (2009) Subendocardial viability index is related to the diastolic/systolic time ratio and left ventricular filling pressure, not to aortic pressure: an invasive study in resting humans. Clin Exp Pharmacol Physiol 36, 4138.
  • 13
    Wilkinson IB, MacCallum H, Rooijmans DF et al. (2000) Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM 93, 4418.
  • 14
    Brooks B, Molyneaux L, Yue DK (1999) Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care 22, 17227.
  • 15
    Tsiachris D, Tsioufis C, Syrseloudis D et al. (2012) Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens 26, 6470.
  • 16
    Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 31524.
  • 17
    Roden M (2009) Diabetes mellitus – Definition, Klassifikation und Diagnose. Wien Klin Wochenschr 121(Suppl. 5), S57.
  • 18
    Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38, 448.
  • 19
    Pieringer H, Schumacher S, Stuby U, Biesenbach G (2009) Augmentation index and large-artery remodeling in patients with longstanding rheumatoid arthritis compared with healthy controls. Semin Arthritis Rheum 39, 1639.
  • 20
    Pauca AL, O'Rourke MF, Kon ND (2001) Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38, 9327.
  • 21
    Chen CH, Nevo E, Fetics B et al. (1997) Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 95, 182736.
  • 22
    Siebenhofer A, Kemp C, Sutton A, Williams B (1999) The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens 13, 6259.
  • 23
    Nauman J, Janszky I, Vatten LJ, Wisløff U (2011) Temporal changes in resting heart rate and deaths from ischemic heart disease. JAMA 306, 257987.
  • 24
    Myasoedova E, Crowson CS, Kremers HM et al. (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70, 4827.
  • 25
    Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372, 80716.
  • 26
    Vesely MR, Dilsizian V (2011) Microvascular angina: assessment of coronary blood flow, flow reserve, and metabolism. Curr Cardiol Rep 13, 1518.